17 research outputs found
Ultrasound Triggered Tumor Oxygenation with Oxygen-Shuttle Nanoperfluorocarbon to Overcome Hypoxia-Associated Resistance in Cancer Therapies
Tumor hypoxia is known to be one
of critical reasons that limit the efficacy of cancer therapies, particularly
photodynamic therapy (PDT) and radiotherapy (RT) in which oxygen is
needed in the process of cancer cell destruction. Herein, taking advantages
of the great biocompatibility and high oxygen dissolving ability of
perfluorocarbon (PFC), we develop an innovative strategy to modulate
the tumor hypoxic microenvironment using nano-PFC as an oxygen shuttle
for ultrasound triggered tumor-specific delivery of oxygen. In our
experiment, nanodroplets of PFC stabilized by albumin are intravenously
injected into tumor-bearing mice under hyperoxic breathing. With a
low-power clinically adapted ultrasound transducer applied on their
tumor, PFC nanodroplets that adsorb oxygen in the lung would rapidly
release oxygen in the tumor under ultrasound stimulation, and then
circulate back into the lung for reoxygenation. Such repeated cycles
would result in dramatically enhanced tumor oxygenation and thus remarkably
improved therapeutic outcomes in both PDT and RT treatment of tumors.
Importantly, our strategy may be applied for different types of tumor
models. Hence, this work presents a simple strategy to promote tumor
oxygenation with great efficiency using agents and instruments readily
available in the clinic, so as to overcome the hypoxia-associated
resistance in cancer treatment
Drug-Induced Self-Assembly of Modified Albumins as Nano-theranostics for Tumor-Targeted Combination Therapy
Paclitaxel (PTX) can bind to human serum albumin (HSA) <i>via</i> hydrophobic interaction, forming Abraxane, which is a U.S. Food and Drug Administration (FDA) approved effective antitumor nanomedicine drug. Herein, the effective antitumor drug PTX is used to induce the self-assembly of HSA modified with either a photosensitizer chlorin e6 (Ce6), which at the same time serves as a chelating agent for Mn<sup>2+</sup> to enable magnetic resonance imaging, or acyclic Arg-Gly-Asp (cRGDyK) peptide that targets αvβ3-integrin overexpressed on tumor angiogenic endothelium. Two types of tumor-targeting theranostic nanoparticles are constructed, either by coassembly of both HSA-Ce6 and HSA-RGD simultaneously or by forming an HSA-Ce6@HSA-RGD core–shell structure, with the assistance of PTX-induced albumin aggregation. Such albumin-based nanoparticles on one hand could targetαvβ3-integrin, as evidenced by both <i>in vitro</i> and <i>in vivo</i> experiments, and on the other hand enable combined photodynamic/chemotherapy, which offers remarkably improved therapeutic efficacy to kill cancer in comparison to the respective monotherapies. Our work presents a new type of tumor-targeted multifunctional albumin-based nanoparticles by drug-induced self-assembly, which is a rather simple method without any sophisticated chemistry or materials engineering and is promising for multimodel imaging-guided combination therapy of cancer
Patterned Substrates of Nano-Graphene Oxide Mediating Highly Localized and Efficient Gene Delivery
A facile
approach was developed to fabricate patterned substrates
of nano-graphene oxide, demonstrating highly localized and efficient
gene delivery to multiple cell lines in a substrate-mediated manner.
The GO substrates served as a valid platform to preconcentrate PEI/pDNA
complexes and maintain their gradual releasing for a relatively long
period of time. Our approach allowed successful gene delivery in selected
groups of cells on the stripe-patterned GO substrates, without transfecting
their neighbor cells directly cultured on glass. These GO substrates
exhibited excellent biocompatibility and enabled effective gene transfection
for various cell lines including stem cells, thus promising important
applications in stem cell research and tissue engineering
Photosensitizer Decorated Red Blood Cells as an Ultrasensitive Light-Responsive Drug Delivery System
Red blood cells (RBCs) have been
widely explored as a natural drug delivery system (DDS) owing to their
inherent biocompatibility and large internal cavities to load various
types of functional molecules. Herein, we uncover that a photosensitizer,
chlorin e6 (Ce6), could be decorated into the membrane of RBCs upon
simple mixing, without affecting the membrane integrity and stability
in dark. Upon light irradiation with a rather low power density, the
singlet oxygen generated by Ce6 would lead to rather efficient disruption
of RBC membrane. With doxorubicin (DOX), a typical chemotherapy drug,
as the model, we engineer a unique type of light-responsive RBC-based
DDS by decorating Ce6 on the cell membrane and loading DOX inside
cells. The light triggered cell membrane breakdown would thus trigger
instant release of DOX, enabling light-controlled chemotherapy with
great specificity. Beyond that our RBC system could also be utilized
for loading of larger biomolecules such as enzymes, whose release
as well as catalytic function is also controlled by light. Our work
thus presents a unique type of biocompatible cell-based DDS that can
be precisely controlled by mild external stimuli, promising not only
for cancer therapy but also for other potential applications in biotechnologies
Functionalization of Graphene Oxide Generates a Unique Interface for Selective Serum Protein Interactions
Potential toxicity and risk of inducing allergy and inflammation
have always been a great concern of using nanomaterials in biomedicine.
In this work, we investigate the serum behaviors of graphene oxide
(GO) and how such behaviors are affected by its surface modification
such as PEGylation. The results show that, when incubated with human
sera, unfunctionalized GO adsorbs a significant amount of serum proteins
and strongly induces complement C3 cleavage (part of the complement
activation cascade), generating C3a/C3aÂ(des-Arg), an anaphylatoxin
involved in local inflammatory responses, whereas PEGylated nano-GO
(nGO-PEG) exhibits dramatic reductions in both protein binding in
general and complement C3 activation. Moreover, we uncover that PEGylation
on GO nanosheets apparently generates an interesting nanointerface,
evidenced by the acquired certain selectivity and increased binding
capacities of nGO-PEG toward a few serum proteins. Further mass spectrometry
analysis identifies six nGO-PEG binding proteins, four of which are
immune-related factors, including C3a/C3aÂ(des-Arg). A series of Western
blot analysis demonstrate that nGO-PEG binds up to 2-fold amount of
C3a/C3aÂ(des-Arg) than unfunctionalized GO, and can efficiently decrease
the level of C3a/C3aÂ(des-Arg) in treated sera, preventing the normal
interaction of C3a with its receptor. In a proof-of-concept experiment,
we demonstrate that nGO-PEG may serve to help eliminate the C3a/C3aÂ(des-Arg)
induced by other nanomaterials such as as-made GO, indicating a new
strategy to modulate the immune responses evoked by one nanomaterial
through the addition of another type of nanomaterial. Our results
highlight the great importance of nanobio interface in regulating
the biological effects of nanomaterials
Graphene Oxide Selectively Enhances Thermostability of Trypsin
In the past few years, graphene and
its derivative, graphene oxide (GO), have been extensively studied
for their applications in biotechnology. In our previous work, we
reported certain PEGylated GOs (GO-PEGs) can selectively promote trypsin
activity and enhance its thermostability. To further explore this,
here we synthesized a series of GO-PEGs with varying PEGylation degrees.
Enzymatic activity assay shows that both GO and GO-PEGs can protect
trypsin, but not chymotrypsin, from thermal denaturation at high temperature.
Surprisingly, the lower the PEGylation degree, the better the protection,
and GO as well as the GO-PEG with the lowest PEGylation degree show
the highest protection efficiency (∼70% retained activity at
70 °C). Fluorescence spectroscopy analysis shows that GO/GO-PEGs
have strong interactions with trypsin. Molecular Dynamics (MD) simulation
results reveal that trypsin is adsorbed onto the surface of GO through
its cationic residues and hydrophilic residues. Different from chymotrypsin
adsorbed on GO, the active site of trypsin is covered by GO. MD simulation
at high temperature shows that, through such interaction with GO,
trypsin’s active site is therefore stabilized and protected
by GO. Our work not only illustrates the promising potential of GO/GO-PEGs
as efficient, selective modulators for trypsin, but also provides
the interaction mechanism of GO with specific proteins at the nano–bio
interface
Theranostic Liposomes with Hypoxia-Activated Prodrug to Effectively Destruct Hypoxic Tumors Post-Photodynamic Therapy
Photodynamic
therapy (PDT), a noninvasive cancer therapeutic method
triggered by light, would lead to severe tumor hypoxia after treatment.
Utilizing a hypoxia-activated prodrug, AQ4N, which only shows toxicity
to cancer cells under hypoxic environment, herein, a multipurpose
liposome is prepared by encapsulating hydrophilic AQ4N and hydrophobic
hexadecylamine conjugated chlorin e6 (<i>h</i>Ce6), a photosensitizer,
into its aqueous cavity and hydrophobic bilayer, respectively. After
chelating a <sup>64</sup>Cu isotope with Ce6, the obtained AQ4N-<sup>64</sup>Cu-<i>h</i>Ce6-liposome is demonstrated to be an
effective imaging probe for <i>in vivo</i> positron emission
tomography, which together with <i>in vivo</i> fluorescence
and photoacoustic imaging uncovers efficient passive homing of those
liposomes after intravenous injection. After being irradiated with
the 660 nm light-emitting diode light, the tumor bearing mice with
injection of AQ4N-<i>h</i>Ce6-liposome show severe tumor
hypoxia, which in turn would trigger activation of AQ4N, and finally
contributes to remarkably improved cancer treatment outcomes <i>via</i> sequential PDT and hypoxia-activated chemotherapy. This
work highlights a liposome-based theranostic nanomedicine that could
utilize tumor hypoxia, a side effect of PDT, to trigger chemotherapy,
resulting in greatly improved efficacy compared to conventional cancer
PDT
Antigen-Loaded Upconversion Nanoparticles for Dendritic Cell Stimulation, Tracking, and Vaccination in Dendritic Cell-Based Immunotherapy
A dendritic cell (DC) vaccine, which is based on efficient antigen delivery into DCs and migration of antigen-pulsed DCs to draining lymph nodes after vaccination, is an effective strategy in initiating CD8<sup>+</sup> T cell immunity for immunotherapy. Herein, antigen-loaded upconversion nanoparticles (UCNPs) are used to label and stimulate DCs, which could be precisely tracked after being injected into animals and induce an antigen-specific immune response. It is discovered that a model antigen, ovalbumin (OVA), could be adsorbed on the surface of dual-polymer-coated UCNPs <i>via</i> electrostatic interaction, forming nanoparticle–antigen complexes, which are efficiently engulfed by DCs and induce DC maturation and cytokine release. Highly sensitive <i>in vivo</i> upconversion luminescence (UCL) imaging of nanoparticle-labeled DCs is successfully carried out, observing the homing of DCs to draining lymph nodes after injection. In addition, strong antigen-specific immune responses including enhanced T cell proliferation, interferon gamma (IFN-γ) production, and cytotoxic T lymphocyte (CTL)-mediated responses are induced by a nanoparticle-pulsed DC vaccine, which is promising for DC-based immunotherapy potentially against cancer
Graphene Oxide–Silver Nanocomposite As a Highly Effective Antibacterial Agent with Species-Specific Mechanisms
Recently, graphene oxide (GO) based
nanocomposites have raised
significant interests in many different areas, one of which being
antibacterial agents where sliver nanoparticle (AgNPs) anchored GO
(GO–Ag) has shown promising potential. However, to our best
knowledge, factors affecting its antibacterial activity as well as
the underlying mechanism remain unclear. In this study, we fabricate
GO–Ag nanocomposites with different AgNPs to GO ratios and
carefully investigate their antibacterial activities against both
the Gram-negative (G−) bacteria Escherichia
coli (E. coli) and
the Gram-positive (G+) bacteria Staphylococcus aureus (S. aureus). We discover that, compared
to AgNPs, GO–Ag nanocomposite with an optimal ratio of AgNPs
to GO is much more effective and shows synergistically enhanced, strong
antibacterial activities at rather low dose (2.5 μg/mL). The
GO–Ag nanocomposite is more toxic to E. coli than that to S. aureus. The antibacterial
effects of GO–Ag nanocomposite are further investigated, revealing
distinct, species-specific mechanisms. The results demonstrate that
GO–Ag nanocomposite functions as a bactericide against the
G– E. coli through disrupting
bacterial cell wall integrity, whereas it exhibits bacteriostatic
effect on the G+ S. aureus by dramatically
inhibiting cell division. Our work not only highlights the great promise
of using GO–Ag as a highly effective antibacterial agent but
also provides more in-depth understandings of the interactions between
microorganisms and GO-based nanocomposites
Seeded Growth of Cu<sub>2–<i>x</i></sub>Se Nanocrystals and Their Size-Dependent Phototherapeutic Effect
Doped
semiconductors supporting localized surface plasmon resonances,
such as nonstoichiometric copper chalcogenides Cu<sub>2–<i>x</i></sub>Se, have been intensively researched for their potential
applications in photoacoustic imaging and photothermal therapy. For
these self-doped nanoparticles, their physicochemical attributes such
as size and surface chemistry will not only affect their cellular
uptake and biodistribution but also influence their own optical properties.
Thus, optimization of the physicochemical properties is crucial for
their nanobio-applications. Through a seeded growth approach, aqueous
phase synthesis of monodisperse Cu<sub>2–<i>x</i></sub>Se with various sizes has been developed for the first time.
Taking three different sized Cu<sub>2–<i>x</i></sub>Se NPs (35, 65, and 105 nm in diameter) as examples, their size-dependent
optical cross-section, photothermal property, and cellular cytotoxicity
have been investigated, and the 65 nm one displays the largest optical
cross-section at 21.57 L g<sup>–1</sup> cm<sup>–1</sup> and best photothermal property per unit mass. In
addition, Cu<sub>2–<i>x</i></sub>Se exhibits a size-dependent
reactive oxygen species generation effect that is inversely proportional
to their diameters. Finally, on the basis of optical property and
cytotoxicity optimizations, the photothermal cancer cell ablation
ability and potential use of Cu<sub>2–<i>x</i></sub>Se NPs as photoacoustic contrast enhancing agent has been demonstrated
in vivo